Intra-arterial chemotherapy for retinoblastoma: An updated systematic review and meta-analysis

Krishnan Ravindran, Lauren A. Dalvin, Jose S Pulido, Waleed Brinjikji

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background and purpose: Intra-arterial chemotherapy for retinoblastoma has been adopted as a first-line treatment option by numerous tertiary centers. The effect of intra-arterial chemotherapy on future rates of metastatic disease as well as on globe salvage in advanced eyes remains relatively unknown. Methods: A search of PubMED, MEDLINE, EMBASE, and Web of Science electronic databases was conducted from inception until January 2019 for studies with a minimum of 10 patients reporting outcomes and complications following intra-arterial chemotherapy for retinoblastoma. Results: A total of 20 studies met the inclusion criteria for analysis, comprising 873 patients and 1467 eyes. Only one study was comparative; there was substantial heterogeneity in reported outcomes and several overlapping patient cohorts that were published. Across all studies, 174 of 1467 eyes were enucleated (11.8%). Metastatic disease occurred in 8 of 513 patients (1.6%). Globe salvage was achieved in 318 of 906 (35.6%) cases of advanced retinoblastoma. The most common ocular complication was retinal detachment, occurring in 23% of eyes, and the most common systemic complications were transient fever and nausea/vomiting. Conclusions: There is a paucity of higher-level evidence with adequate follow-up surrounding the long-term safety of intra-arterial chemotherapy and effect on metastasis in retinoblastoma. Studies to date have been limited by short-term follow-up. Longitudinal prospective studies could provide greater insight into the ability of intra-arterial chemotherapy to reduce the risk of retinoblastoma metastasis.

Original languageEnglish (US)
JournalJournal of neurointerventional surgery
DOIs
StatePublished - Jan 1 2019

Fingerprint

Retinoblastoma
Meta-Analysis
Drug Therapy
Neoplasm Metastasis
Retinal Detachment
MEDLINE
Nausea
Vomiting
Longitudinal Studies
Fever
Databases
Prospective Studies
Safety

Keywords

  • guidewire
  • intervention
  • orbit

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

@article{5c35f8cd7fa94a67b4d3d77e703a5a52,
title = "Intra-arterial chemotherapy for retinoblastoma: An updated systematic review and meta-analysis",
abstract = "Background and purpose: Intra-arterial chemotherapy for retinoblastoma has been adopted as a first-line treatment option by numerous tertiary centers. The effect of intra-arterial chemotherapy on future rates of metastatic disease as well as on globe salvage in advanced eyes remains relatively unknown. Methods: A search of PubMED, MEDLINE, EMBASE, and Web of Science electronic databases was conducted from inception until January 2019 for studies with a minimum of 10 patients reporting outcomes and complications following intra-arterial chemotherapy for retinoblastoma. Results: A total of 20 studies met the inclusion criteria for analysis, comprising 873 patients and 1467 eyes. Only one study was comparative; there was substantial heterogeneity in reported outcomes and several overlapping patient cohorts that were published. Across all studies, 174 of 1467 eyes were enucleated (11.8{\%}). Metastatic disease occurred in 8 of 513 patients (1.6{\%}). Globe salvage was achieved in 318 of 906 (35.6{\%}) cases of advanced retinoblastoma. The most common ocular complication was retinal detachment, occurring in 23{\%} of eyes, and the most common systemic complications were transient fever and nausea/vomiting. Conclusions: There is a paucity of higher-level evidence with adequate follow-up surrounding the long-term safety of intra-arterial chemotherapy and effect on metastasis in retinoblastoma. Studies to date have been limited by short-term follow-up. Longitudinal prospective studies could provide greater insight into the ability of intra-arterial chemotherapy to reduce the risk of retinoblastoma metastasis.",
keywords = "guidewire, intervention, orbit",
author = "Krishnan Ravindran and Dalvin, {Lauren A.} and Pulido, {Jose S} and Waleed Brinjikji",
year = "2019",
month = "1",
day = "1",
doi = "10.1136/neurintsurg-2019-014909",
language = "English (US)",
journal = "Journal of NeuroInterventional Surgery",
issn = "1759-8478",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Intra-arterial chemotherapy for retinoblastoma

T2 - An updated systematic review and meta-analysis

AU - Ravindran, Krishnan

AU - Dalvin, Lauren A.

AU - Pulido, Jose S

AU - Brinjikji, Waleed

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background and purpose: Intra-arterial chemotherapy for retinoblastoma has been adopted as a first-line treatment option by numerous tertiary centers. The effect of intra-arterial chemotherapy on future rates of metastatic disease as well as on globe salvage in advanced eyes remains relatively unknown. Methods: A search of PubMED, MEDLINE, EMBASE, and Web of Science electronic databases was conducted from inception until January 2019 for studies with a minimum of 10 patients reporting outcomes and complications following intra-arterial chemotherapy for retinoblastoma. Results: A total of 20 studies met the inclusion criteria for analysis, comprising 873 patients and 1467 eyes. Only one study was comparative; there was substantial heterogeneity in reported outcomes and several overlapping patient cohorts that were published. Across all studies, 174 of 1467 eyes were enucleated (11.8%). Metastatic disease occurred in 8 of 513 patients (1.6%). Globe salvage was achieved in 318 of 906 (35.6%) cases of advanced retinoblastoma. The most common ocular complication was retinal detachment, occurring in 23% of eyes, and the most common systemic complications were transient fever and nausea/vomiting. Conclusions: There is a paucity of higher-level evidence with adequate follow-up surrounding the long-term safety of intra-arterial chemotherapy and effect on metastasis in retinoblastoma. Studies to date have been limited by short-term follow-up. Longitudinal prospective studies could provide greater insight into the ability of intra-arterial chemotherapy to reduce the risk of retinoblastoma metastasis.

AB - Background and purpose: Intra-arterial chemotherapy for retinoblastoma has been adopted as a first-line treatment option by numerous tertiary centers. The effect of intra-arterial chemotherapy on future rates of metastatic disease as well as on globe salvage in advanced eyes remains relatively unknown. Methods: A search of PubMED, MEDLINE, EMBASE, and Web of Science electronic databases was conducted from inception until January 2019 for studies with a minimum of 10 patients reporting outcomes and complications following intra-arterial chemotherapy for retinoblastoma. Results: A total of 20 studies met the inclusion criteria for analysis, comprising 873 patients and 1467 eyes. Only one study was comparative; there was substantial heterogeneity in reported outcomes and several overlapping patient cohorts that were published. Across all studies, 174 of 1467 eyes were enucleated (11.8%). Metastatic disease occurred in 8 of 513 patients (1.6%). Globe salvage was achieved in 318 of 906 (35.6%) cases of advanced retinoblastoma. The most common ocular complication was retinal detachment, occurring in 23% of eyes, and the most common systemic complications were transient fever and nausea/vomiting. Conclusions: There is a paucity of higher-level evidence with adequate follow-up surrounding the long-term safety of intra-arterial chemotherapy and effect on metastasis in retinoblastoma. Studies to date have been limited by short-term follow-up. Longitudinal prospective studies could provide greater insight into the ability of intra-arterial chemotherapy to reduce the risk of retinoblastoma metastasis.

KW - guidewire

KW - intervention

KW - orbit

UR - http://www.scopus.com/inward/record.url?scp=85065874661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065874661&partnerID=8YFLogxK

U2 - 10.1136/neurintsurg-2019-014909

DO - 10.1136/neurintsurg-2019-014909

M3 - Article

AN - SCOPUS:85065874661

JO - Journal of NeuroInterventional Surgery

JF - Journal of NeuroInterventional Surgery

SN - 1759-8478

ER -